Oracle, for its part, is seeking redress from a Delaware court for PeopleSofts poison pill anti-takeover measure. Also at issue is PeopleSofts controversial Customer Assurance Program that looks to reimburse between two and five times the license fees to some customers in the event of a takeover. The various efforts by Oracle are being coordinated by Vice Chancellor Strine, the Delaware judge overseeing that case.An Oracle spokeswoman said it is not clear yet who Oracle has requested to interview at PeopleSoft, despite PeopleSofts clear indication of who it expects to interview during its first phase of depositions, to commence this month. Strine has set aside the weeks of March 29 and April 5 for a trial, set in Delaware, on Oracles claims. PeopleSoft, for its part, anticipates a response from Oracle regarding its suit this Friday. (Editors Note: This story has been updated since its original posting to include information on the EUs deadline.)
As a result, Oracle expects to be in depositions regarding the CAP program in January, and in reciprocal depositions with PeopleSoft beginning in early February and continuing into March, according to court documents.